Articles written by: Nichole Whelan

Reviewing Arbutus Biopharma Corporation (ABUS)’s and CorMedix Inc. (NYSEAMERICAN:CRMD)’s results

Since Arbutus Biopharma Corporation (NASDAQ:ABUS) and CorMedix Inc. (NYSEAMERICAN:CRMD) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation of both companies. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing CRISPR Therapeutics AG (CRSP)’s and Audentes Therapeutics Inc. (NASDAQ:BOLD)’s results

CRISPR Therapeutics AG (NASDAQ:CRSP) and Audentes Therapeutics Inc. (NASDAQ:BOLD) compete against each other in the Biotechnology sector. We will contrast them and contrast their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CRISPR Therapeutics […]

Reviewing BT Group plc (BT)’s and Cable One Inc. (NYSE:CABO)’s results

BT Group plc (NYSE:BT) and Cable One Inc. (NYSE:CABO), both competing one another are Diversified Communication Services companies. We will contrast their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BT Group plc N/A […]

Brookfield Asset Management Has Increased Kinder Morgan Del (KMI) Stake By $1.49 Million; Martin Marietta Materials Has 0.95 Sentiment

Brookfield Asset Management Has Increased Kinder Morgan Del (KMI) Stake By $1.49 Million; Martin Marietta Materials Has 0.95 Sentiment

Martin Marietta Materials Inc (MLM) investors sentiment decreased to 0.95 in Q4 2018. It’s down -0.25, from 1.2 in 2018Q3. The ratio turned negative, as 198 hedge funds started new and increased holdings, while 209 cut down and sold positions in Martin Marietta Materials Inc. The hedge funds in our […]

Springbok Capital Management Has Lowered By $838,155 Its Neurocrine Biosciences (NBIX) Position; Automatic Data Processing, Inc. (ADP) Covered By 1 Bulls

Springbok Capital Management Has Lowered By $838,155 Its Neurocrine Biosciences (NBIX) Position; Automatic Data Processing, Inc. (ADP) Covered By 1 Bulls

Springbok Capital Management Llc decreased Neurocrine Biosciences Inc (NBIX) stake by 98.02% reported in 2018Q4 SEC filing. Springbok Capital Management Llc sold 11,805 shares as Neurocrine Biosciences Inc (NBIX)’s stock declined 11.62%. The Springbok Capital Management Llc holds 239 shares with $17,000 value, down from 12,044 last quarter. Neurocrine Biosciences […]